Gangrene

For other uses, see Gangrene (disambiguation).

Gangrene
Other names	Gangrenous necrosis
Dry gangrene affecting the toes as a result of peripheral artery disease
Specialty	Infectious disease, surgery, podiatry
Symptoms	Change in skin color to red or black, numbness, pain, skin breakdown, coolness [1]
Complications	Sepsis, amputation [1] [2]
Types	Dry, wet, gas, internal, necrotizing fasciitis [3]
Risk factors	Diabetes, peripheral arterial disease, smoking, major trauma, alcoholism, plague, HIV/AIDS, frostbite, Raynaud's syndrome [3] [4]
Diagnostic method	Based on symptom, With medical imaging used to identify the underlying cause.
Treatment	Depends on underlying cause [5]
Prognosis	Variable
Frequency	Unknown [2]

Gangrene toes in a diabetic

Gangrene is a type of tissue death caused by a lack of blood supply. ^[4] The feet and hands are most commonly affected. ^[1] If the gangrene is caused by an infectious agent, it may present with a fever or sepsis. ^[1]

Symptoms may include: ^[1]

• a change in skin color to red or black
• numbness
• swelling
• pain
• skin breakdown
• coolness

Common risk factors include, but are not limited to, diabetes, peripheral arterial disease, smoking, major trauma, alcoholism, HIV/AIDS, frostbite, influenza, dengue fever, malaria, chickenpox, plague, hypernatremia, radiation injuries, meningococcal disease, Group B streptococcal infection and Raynaud's syndrome. ^{[3] [4]}

It can be classified as dry gangrene, wet gangrene, gas gangrene, internal gangrene, and necrotizing fasciitis. ^[3] The diagnosis of gangrene is based on history and physical examination and supported by tests such as medical imaging. ^[6]

Main classifications: ^[7]

• Dry Gangrene: A type of coagulative necrosis that is caused by lack of blood supply leading to ischemia and death of the tissue.
• Wet Gangrene: A type of liquefactive necrosis where the death of tissue due to lack of blood supply simultaneously occurring with a bacterial infection.
• Gas Gangrene: A type of liquefactive necrosis where the superimposed bacterial infection is caused by gas-producing bacteria such as some of the Clostridia.

Treatment may involve surgery to remove the dead tissue, antibiotics to treat any infection, and efforts to address the underlying cause. ^[5] Surgical efforts may include debridement, amputation, or the use of maggot therapy. ^[5] Efforts to treat the underlying cause may include operative procedures such as bypass surgery or endovascular interventions such as stenting or angioplasty. ^[5] In certain cases, hyperbaric oxygen therapy may be useful. ^[5] How commonly the condition occurs is unknown. ^[2]

Etymology

The etymology of gangrene derives from the Latin word gangraena and from the Greek gangraina (γάγγραινα), which means "putrefaction of tissues". ^[8]

Pathogenesis

Healthy cells maintain a balance called homeostasis, constantly adjusting to various stressors and stimuli from their environment. When a cell can't adapt properly to these changes, it suffers a reversible injury. However, if the cell can't return to its normal state and continues to be exposed to stress or damage, the injury becomes irreversible. This can eventually lead to cell death, either through necrosis (a pathological process) or apoptosis (often a normal, physiological process).

Necrosis is indeed an unregulated form of cell death, unlike apoptosis, which is a more controlled, programmed process. When tissues undergo necrosis, they swell, rupture, and release their contents, which can trigger inflammation and further tissue damage. When a large area of tissue is affected by necrosis, it can lead to gangrene. Gangrene itself happens when the tissue loses blood flow and becomes deprived of oxygen and nutrients. Without proper blood supply, cells in the affected area start dying, leading to decay. There are different types of gangrene, including dry, wet, and gas gangrene, depending on the underlying cause and the conditions of the tissue.

Signs and symptoms

An illustration showing four different stages of gangrene, including one (Fig. 4 top right) caused by an obstacle to the return of the venous blood due to heart disease.

Dry Gangrene

^[9]

• Color Change: The affected area turns brown, then darkens to a black or purplish color.
• Dryness: The skin becomes dry and shriveled.
• Coldness: The affected area may feel cold to the touch.
• Loss of Sensation: Numbness or a loss of feeling in the affected area.
• Odor: Typically no odor, as there is no infection involved, but the tissue itself is dead.

Wet Gangrene

^[9]

• Swelling: The affected area may become swollen and puffy.
• Foul Smell: A very distinct, unpleasant, and foul odor due to bacterial infection.
• Redness: The skin over the affected tissue may become red, inflamed, and hot.
• Pain: Severe pain in the affected area, which may eventually subside as the tissue dies.
• Blisters: Large, fluid-filled blisters may form over the tissue.
• Pus: The tissue may discharge pus if infected.
• Fever: Systemic symptoms such as fever may occur as the infection spreads.

Gas Gangrene

^[9]

• Severe Pain: Sudden and severe pain at the site of infection.
• Gas Crepitus: A crackling sound or sensation under the skin, caused by gas bubbles produced by the infecting bacteria.
• Darkening of Skin: The skin may turn dark, often with a greenish or black tint.
• Swelling: Rapid swelling in the affected area, often with a rapid progression of tissue necrosis.
• Systemic Symptoms: Fever, tachycardia (increased heart rate), hypotension (low blood pressure), and shock due to the spread of infection.
• Foul Odor: A distinctive, often sweet or rotten smell due to the gas produced by bacteria.

Causes

Gangrene is caused by a critically insufficient blood supply (e.g., peripheral vascular disease) or infection. ^{[3] [10] [11]} It is associated with diabetes ^[12] and long-term tobacco smoking. ^{[4] [3]}

Dry gangrene

Dry gangrene is a form of coagulative necrosis that develops in ischemic tissue, where the blood supply is inadequate to keep tissue viable. It is not a disease itself, but a symptom of other diseases. ^[13] The term dry is used only when referring to a limb or to the gut (in other locations, this same type of necrosis is called an infarction, such as myocardial infarction). ^[14] Dry gangrene is often due to peripheral artery disease, but can be due to acute limb ischemia. As a result, people with atherosclerosis, high cholesterol, diabetes and smokers commonly have dry gangrene. ^[15] The limited oxygen in the ischemic limb limits putrefaction and bacteria fail to survive. The affected part is dry, shrunken, and dark reddish-black. The line of separation usually brings about complete separation, with eventual falling off of the gangrenous tissue if it is not removed surgically, a process called autoamputation. ^[15]

Dry gangrene is the result of chronic ischemia without infection. If ischemia is detected early, when ischemic wounds rather than gangrene are present, the process can be treated by revascularization (via vascular bypass or angioplasty). ^[16] However, once gangrene has developed, the affected tissues are not salvageable. ^[17] Because dry gangrene is not accompanied by infection, it is not as emergent as gas gangrene or wet gangrene, both of which have a risk of sepsis. Over time, dry gangrene may develop into wet gangrene if an infection develops in the dead tissues. ^[18]

Diabetes mellitus is a risk factor for peripheral vascular disease, thus for dry gangrene, but also a risk factor for wet gangrene, particularly in patients with poorly controlled blood sugar levels, as elevated serum glucose creates a favorable environment for bacterial infection. ^[19]

Wet gangrene

Wet gangrene of the foot.

Wet, or infected, gangrene is characterized by thriving bacteria and has a poor prognosis (compared to dry gangrene) due to sepsis resulting from the free communication between infected fluid and circulatory fluid. In wet gangrene, the tissue is infected by saprogenic microorganisms ( Clostridium perfringens or Bacillus fusiformis , for example), which cause tissue to swell and emit a foul odor. Wet gangrene usually develops rapidly due to blockage of venous (mainly) or arterial blood flow. ^[15] The affected part is saturated with stagnant blood, which promotes the rapid growth of bacteria. The toxic products formed by bacteria are absorbed, causing systemic manifestation of sepsis and finally death. The affected part is edematous, soft, putrid, rotten, and dark.^{[ citation needed ]}

Because of the high mortality associated with infected gangrene (about 80% without treatment and 20% with treatment), an emergency salvage amputation, such as a guillotine amputation, is often needed to limit systemic effects of the infection. ^[20] Such an amputation can be converted to a formal amputation, such as a below- or above-knee amputation. ^[20]

Gas gangrene

Main article: Gas gangrene

Gas gangrene is a bacterial infection that produces gas within tissues. It can be caused by Clostridium , most commonly alpha toxin-producing C. perfringens, or various nonclostridial species. ^{[11] [21]} Infection spreads rapidly as the gases produced by the bacteria expand and infiltrate healthy tissue in the vicinity. Because of its ability to quickly spread to surrounding tissues, gas gangrene should be treated as a medical emergency.

Gas gangrene is caused by bacterial exotoxin-producing clostridial species, which are mostly found in soil, and other anaerobes such as Bacteroides and anaerobic streptococci. These environmental bacteria may enter the muscle through a wound and subsequently proliferate in necrotic tissue and secrete powerful toxins that destroy nearby tissue, generating gas at the same time. A gas composition of 5.9% hydrogen, 3.4% carbon dioxide, 74.5% nitrogen, and 16.1% oxygen was reported in one clinical case. ^[22]

Gas gangrene can cause necrosis, gas production, and sepsis. Progression to toxemia and shock is often very rapid. ^[23]

Other types

• Necrotizing fasciitis is a rare infection that spreads deep into the body along tissue planes. It is categorized into four subtypes, with the first two being the most common. Type 1 requires an infection with an anaerobe and a species in the Enterobacteriaceae family, while type 2 is characterized by infection with Streptococcus pyogenes , a Gram-positive cocci bacteria, and thus is also known as hemolytic streptococcal gangrene. ^{[24] [25]}
• Noma is a gangrene of the face most often found in Africa, Southeast Asia and South America. ^[26]
• Fournier gangrene is a type of necrotizing fasciitis that usually affects the genitals and groin. ^[27]
• Venous limb gangrene may be caused by Heparin-induced thrombocytopenia and thrombosis. ^[28]
• Severe mesenteric ischemia may result in gangrene of the small intestine.^{[ citation needed ]}
• Severe ischemic colitis may result in gangrene of the large intestine.^{[ citation needed ]}

Treatment

Treatment varies based on the severity and type of gangrene. ^[15]

Lifestyle

Exercises like walking and massage therapy may be beneficial. ^[15] It is also recommended to discontinue smoking, as this helps prevent further damage to the blood vessel walls and supports better blood flow. ^[29] For patients experiencing claudication, exercise training programs that progressively increase in intensity are encouraged to promote blood flow to the lower extremities. ^[29] Additional measures to prevent ischemic gangrene, particularly in cases of critical limb ischemia, include proper foot care—such as wearing well-fitting, protective shoes—and avoiding tight clothing that can restrict blood flow. ^[29] For diabetic patients, adherence to their treatment plan is crucial, which includes consistent use of medication, a balanced diet to manage blood sugar levels, and daily foot inspections to monitor for wounds.

Medication

Medications may include pain management, medications that promote circulation in the circulatory system and antibiotics. Since gangrene is associated with periodic pain caused by too little blood flow, pain management is important so patients can continue doing exercises that promote circulation. Pain management medications can include opioids and opioid-like analgesics. Since gangrene is a result of ischemia, circulatory system management is important. These medications can include antiplatelet drug, anticoagulant, and fibrinolytics. Prevention and management of ischemic gangrene also includes maintaining normal blood pressure through use of anti-hypertensive medications such as beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. ^[29] To prevent further blockage of blood vessels, treatment of co-morbid hypercholesterolemia through lipid-lowering medications such as statins is recommended. ^[29] Pentoxifylline is a medication that is described to improve blood flow and tissue oxygenation, although its efficacy is unknown it has shown to boost excercise duration. ^[29]

As infection is often associated with gangrene, antibiotics are often a critical component of its treatment. The life-threatening nature of gangrene requires treatment with intravenous antibiotics in an inpatient setting. ^[15] Antibiotics alone are not effective because they may not penetrate infected tissues sufficiently. ^[30] Antibiotic treatment of gas gangrene, except for C. tertium infections which is treated with vancomycin or metronidazole intravenously, is typically penicillin and clindamycin for about two weeks. ^[31] For consideration, there has been noted resistance of clindamycin in C. perfringens infections in different parts of the world. In order to provide the most optimal treatment plan, microbiology susceptibility testing would provide additional information for the clinician in terms what antibiotics would work the best. ^[31]

Surgery

Surgical removal of all dead tissue, however, is the mainstay of treatment for gangrene. Surgical inspection, blood cultures (to rule out bacteremia) and gram-staining for histopathologic examination is indicated of any patients suspected to have gas gangrene regardless of cause. ^[31] Often, gangrene is associated with underlying infection, thus the gangrenous tissue must be debrided to hinder the spread of the associated infection. Delayed closure of wounds after debridement ensures that the site is clear of any infection. ^[31] The extent of surgical debridement needed depends on the extent of the gangrene and may be limited to the removal of a finger, toe, or ear, but in severe cases may involve a limb amputation. ^[15] Ischemic disease of the legs is the most common reason for amputations. In about a quarter of these cases, the other side requires amputation in the next three years. ^[32]

Dead tissue alone does not require debridement, and in some cases, such as dry gangrene, the affected part falls off (autoamputates), making surgical removal unnecessary. Waiting for autoamputation, however, may cause health complications as well as decreased quality of life. ^[15]

After the gangrene is treated with debridement and antibiotics, the underlying cause can be treated. In the case of gangrene due to critical limb ischemia, revascularization can be performed to treat the underlying peripheral underlateral artery disease. ^[29] To prevent complications of gangrene from critical limb ischemia, revascularization procedures can be utilized for severely symptomatic patients that are refractory to medications. ^[29] Angioplasty should be considered if severe blockage in lower leg vessels (tibial and peroneal artery) leads to gangrene. ^[33] Additional revascularization procedures that are performed endovascularly include stenting and atherectomies to remove blockage. ^[29] Surgical interventions available include different types of femoral bypass (such as femoral-popliteal, femoral-femoral, axillo-femoral, etc.) or aortoiliac endarterectomy, both aimed at restoring blood flow to the tissues of the lower extremities. ^[29]

Other

Hyperbaric oxygen therapy treatment is used to treat gas gangrene. It increases pressure and oxygen content to allow blood to carry more oxygen to inhibit anaerobic organism growth and reproduction. ^[34] Hyperbaric oxygen as a monotherapy is controversial in its lack of efficacy, surgery and antibiotic administrations remains to be the mainstay of treatment for gas gangrene. ^[31] However, hyperbaric oxygen therapy can be utilized as an adjunctive treatment and may provide some benefit.

Regenerative medical treatments and stem-cell therapies have successfully altered gangrene and ulcer prognosis.^{[ citation needed ]}

Prognosis

Gas Gangrene

The prognosis of such a rapidly progressive disease requires timely diagnosis with prompt surgical debridement and administration of antibiotics. Gas gangrene that involves trunk or visceral organs compared to the extremities are typically harder to treat due to its locations making debridement difficult. If gas gangrene is left untreated, then it can progress to bacteremia and progress to death. Mortality rates are particularly high for patients that present with shock and those that present with spontaneous gas gangrene infected with C. septicum. ^[31]

History

Union Army Private Milton E. Wallen lies in bed with a gangrenous amputated arm

As early as 1028, flies and maggots were commonly used to treat chronic wounds or ulcers to prevent or arrest necrotic spread, ^[35] as some species of maggots consume only dead flesh, leaving nearby living tissue unaffected. This practice largely died out after the introduction of antibiotics to the range of treatments for wounds. In recent times, however, maggot therapy has regained some credibility and is sometimes employed with great efficacy in cases of chronic tissue necrosis. ^{[36] [37] [38]}

The French Baroque composer Jean-Baptiste Lully contracted gangrene in January 1687 when, while conducting a performance of his Te Deum , he stabbed his own toe with his pointed staff (which was used as a baton). The disease spread to his leg, but the composer refused to have his toe amputated, which eventually led to his death in March of that year. ^[39]

French King Louis XIV died of gangrene in his leg on 1 September 1715, four days prior to his 77th birthday. ^[40]

Sebald Justinus Brugmans, Professor at Leyden University, from 1795 on Director of the Medical Bureau of the Batavian Republic, and inspector-general of the French Imperial Military Health-Service in 1811, became a leading expert in the fight against hospital-gangrene and its prevention. He wrote a treatise on gangrene in 1814 in which he meticulously analyzed and explained the causes of this dreadful disease, which he was convinced was contagious. He completed his entry with a thorough evaluation of all possible and well experienced sanitary regulations. His work was very well received and was instrumental in convincing most later authors that gangrene was a contagious disease. ^{[41] [42]}

John M. Trombold wrote: "Middleton Goldsmith, a surgeon in the Union Army during the American Civil War, meticulously studied hospital gangrene and developed a revolutionary treatment regimen. The cumulative Civil War hospital gangrene mortality was 45%. Goldsmith's method, which he applied to over 330 cases, yielded a mortality under 3%." ^[43] Goldsmith advocated the use of debridement and topical and injected bromide solutions on infected wounds to reduce the incidence and virulence of "poisoned miasma". Copies of his book ^[44] were issued to Union surgeons to encourage the use of his methods. ^[45]

References

1. "Gangrene Symptoms". NHS. 13 October 2015. Retrieved 12 December 2017.
2. "Gangrene". patient.info. 12 March 2014. Retrieved 12 December 2017.
3. "Gangrene Causes". NHS. 13 October 2015. Retrieved 12 December 2017.
4. "Gangrene". NHS. 13 October 2015. Retrieved 12 December 2017.
5. "Gangrene Treatment". NHS. Retrieved 12 December 2017.
6. "Gangrene Diagnosis". NHS. 13 October 2015. Retrieved 12 December 2017.
7. Kumar, Vinay; Abbas, Abul K.; Aster, Jon C.; Deyrup, Andrea T.; Das, Abhijit (2023). Robbins, Stanley L. (ed.). Robbins & Kumar basic pathology (11th ed.). Philadelphia, Pa: Elsevier. pp. Chapter: 1 Cell Injury, Cell Death, and Adaptations. ISBN   978-0-323-79018-5.
8. Liddell & Scott's Lexicon, Oxford University Press, 1963 edition
9. "Sore, shiny and swollen skin: Is it gangrene?-Gangrene - Symptoms & causes". Mayo Clinic. Retrieved 2025-01-29.
10. Gardner, AW; Afaq, A (November–December 2008). "Management of lower extremity peripheral arterial disease". Journal of Cardiopulmonary Rehabilitation and Prevention. 28 (6): 349–57. doi:10.1097/HCR.0b013e31818c3b96. PMC   2743684 . PMID   19008688.
11. Yang, Z; Hu, J; Qu, Y; Sun, F; Leng, X; Li, H; Zhan, S (3 December 2015). "Interventions for treating gas gangrene". The Cochrane Database of Systematic Reviews. 2015 (12): CD010577. doi:10.1002/14651858.CD010577.pub2. PMC   8652263 . PMID   26631369.
12. Korzon-Burakowska, A; Dziemidok, P (December 2011). "Diabetic foot-the need for comprehensive multidisciplinary approach". Annals of Agricultural and Environmental Medicine. 18 (2): 314–17. PMID   22216805.
13. Smith, Tyler (2015). Gangrene Management: Today and Tomorrow. Hayle Medical. ISBN   978-1632412232.^{[ page needed ]}
14. Cross, Simon (2018). Underwood's Pathology: A Clinical Approach (7th ed.). Elsevier Health Sciences. p. 124. ISBN   9780702072109 . Retrieved 8 April 2020.
15. Al Wahbi, Abdullah (2018-06-01). "Autoamputation of diabetic toe with dry gangrene: a myth or a fact?". Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 11: 255–264. doi: 10.2147/DMSO.S164199 . ISSN   1178-7007. PMC   5987754 . PMID   29910628.
16. Aiello A, Anichini R, Brocco E, Caravaggi C, Chiavetta A, Cioni R, Da Ros R, De Feo ME, Ferraresi R, Florio F, Gargiulo M, Galzerano G, Gandini R, Giurato L, Graziani L, Mancini L, Manzi M, Modugno P, Setacci C, Uccioli L (2014). "Treatment of peripheral arterial disease in diabetes: a consensus of the Italian Societies of Diabetes (SID, AMD), Radiology (SIRM) and Vascular Endovascular Surgery (SICVE)". Nutr Metab Cardiovasc Dis. 24 (4): 355–69. doi: 10.1016/j.numecd.2013.12.007 . PMID   24486336.
17. Gerhard-Herman, MD; Gornik, HL; Barrett, C; Barshes, NR; Corriere, MA; Drachman, DE; Fleisher, LA; Fowkes, FG; Hamburg, NM; Kinlay, S; Lookstein, R; Misra, S; Mureebe, L; Olin, JW; Patel, RA; Regensteiner, JG; Schanzer, A; Shishehbor, MH; Stewart, KJ; Treat-Jacobson, D; Walsh, ME (2017). "2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. 135 (12): e726–79. doi:10.1161/CIR.0000000000000471. PMC   5477786 . PMID   27840333.
18. Nather, Aziz (2013). The diabetic foot. World Scientific. ISBN   978-9814417006.
19. Vayvada, H; Demirdover, C; Menderes, A; Karaca, C (August 2013). "Necrotising fasciitis in the central part of the body: diagnosis, management and review of the literature". International Wound Journal. 10 (4): 466–72. doi:10.1111/j.1742-481x.2012.01006.x. PMC   7950796 . PMID   22694053. S2CID   5693425.
20. Tisi, PV; Than, MM (8 April 2014). "Type of incision for below knee amputation". The Cochrane Database of Systematic Reviews. 2014 (4): CD003749. doi:10.1002/14651858.CD003749.pub3. PMC   7154343 . PMID   24715679.
21. Sakurai, J.; Nagahama, M.; Oda, M. (November 2004). "Clostridium perfringens alpha-toxin: characterization and mode of action". Journal of Biochemistry . 136 (5): 569–74. doi:10.1093/jb/mvh161. PMID   15632295. S2CID   12940936.
22. Chi CH, Chen KW, Huang JJ, Chuang YC, Wu MH (December 1995). "Gas composition in Clostridium septicum gas gangrene". Journal of the Formosan Medical Association. 94 (12): 757–59. PMID   8541740.
23. "Gas Gangrene". The Lecturio Medical Concept Library. Retrieved 22 July 2021.
24. "For Clinicians: Type II Necrotizing Fasciitis". www.cdc.gov. 2019-02-21. Retrieved 2019-08-05.
25. Puvanendran, Rukshini; Chan Meng Huey, Jason; Pasupathy, Shanker (2009). "Necrotizing fasciitis". Canadian Family Physician. 55 (10). cfpmfc: 981–987. PMC   2762295 . PMID   19826154.
26. Sivapathasundharam, B.; Rajendran, Arya (30 June 2012). Shafer's Textbook of Oral Pathology. Elsevier Health Sciences. p. 333. ISBN   978-81-312-3800-4.
27. Levenson, RB; Singh, AK; Novelline, RA (March–April 2008). "Fournier gangrene: role of imaging". Radiographics. 28 (2): 519–28. doi:10.1148/rg.282075048. PMID   18349455. S2CID   2930176.
28. Warkentin, TE (August 2010). "Agents for the treatment of heparin-induced thrombocytopenia". Hematology/Oncology Clinics of North America. 24 (4): 755–75. doi:10.1016/j.hoc.2010.05.009. PMID   20659659.
29. Loscalzo, Joseph; Fauci, Anthony S.; Kasper, Dennis L.; Hauser, Stephen L.; Longo, Dan L.; Jameson, J. Larry, eds. (2022). Harrison's principles of internal medicine (21st ed.). New York: McGraw Hill. pp. Chapter 281. ISBN   978-1-264-26851-1.
30. Lipsky BA (December 1999). "Evidence-based antibiotic therapy of diabetic foot infections". FEMS Immunol. Med. Microbiol. 26 (3–4): 267–76. doi: 10.1016/s0928-8244(99)00143-1 . PMID   10575138.
31. Harrison's principles of internal medicine (21st ed.). New York: McGraw Hill. 2022. pp. Chapter 154. ISBN   978-1-264-26850-4.
32. Amputations of the Lower Extremity at eMedicine
33. "Angioplasty and stent placement – peripheral arteries" . Retrieved July 24, 2013.
34. Liu R, Li L, Yang M, Boden G, Yang G (2013). "Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers". Mayo Clin. Proc. 88 (2): 166–75. doi:10.1016/j.mayocp.2012.10.021. PMID   23374620.
35. Shi, Eric; Shofler, David (2014). "Maggot debridement therapy: A systematic review". British Journal of Community Nursing. 19: S6 –S13. doi:10.12968/bjcn.2014.19.Sup12.S6. PMID   25478859.
36. "Product Classification: Maggots, Medical". fda.gov. US: Food and Drug Administration.
37. "FDA CDRH 510(k) summary" (PDF).
38. Sun, Xinjuan; Jiang, Kechun; Chen, Jingan; et al. (2014). "A systematic review of maggot debridement therapy for chronically infected wounds and ulcers". International Journal of Infectious Diseases . 25: 32–7. doi: 10.1016/j.ijid.2014.03.1397 . PMID   24841930.
39. "Music Trivia – The Death of Lully". The Musician's Lounge. Utah Symphony Orchestra. August 2010. Retrieved March 7, 2017.
40. Laurenson, John (21 November 2015). "The strange death of Louis XIV". The Spectator. Retrieved 12 March 2017.
41. Teun van Heiningen, "Sebald Justinus Brugmans' strijd tegen de hospitaalversterving", Leiden University, URN:NBN:NL:UI:10-1-112565
42. Brugmans, Sebald Justinus (May 24, 1814). "Verhandeling ter beantwoording der vrage: Kan de gesteldheid en zamenstelling van den dampkring, welke onmiddelijk tot de Hospitaal-versterving (Gangraena NosocomialisZ) aanleiding geeft, door Natuur- of Scheikundige middelen worden ontdekt?". J. van der Heij – via Google Books.
43. Trombold JM (2011). "Gangrene therapy and antisepsis before lister: the civil war contributions of Middleton Goldsmith of Louisville". Am Surg. 77 (9): 1138–43. doi: 10.1177/000313481107700924 . PMID   21944621. S2CID   26732207.
44. A report on hospital gangrene, erysipelas and pyaemia. 1863
45. Watson, Dr. Scott. "Hospital Gangrene During The Civil War – Civil War Medicine" . Retrieved 2014-04-15.

External links

• Media related to Gangrene at Wikimedia Commons